ArticleClinical and experimental medicine2023

Efficacy and safety of Orelabrutinib-based regimens in diffuse large B-cell lymphoma: a single-center retrospective analysis.

Ruowen Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.